Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 446 (TSX: $AVCN.TO)
(TSX: $HEXO.TO) (TSX: $ZENA.TO) (OTC: $EHVVF)
Delta, Kelowna, BC, July 24, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/07241AVCN-HEXO-ZENA-EHVVF.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Avicanna
Inc.
(TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company
focused on the development, manufacturing and commercialization of
plant-derived cannabinoid-based products, announced that the Company's research
collaborators have received two independent peer-reviewed grants from the
Natural Sciences and Engineering Research Council of Canada. The NSERC Alliance
grants will be used to expand the investigators' collaborative research with
Avicanna.
For the past three years, Dr.
Christine Allen's research group (CARG) in the Leslie Dan Faculty of Pharmacy
at the University of Toronto has supported the development and optimization of
Avicanna's cannabinoid-based products including commercial cosmetics (Pura
H&W) and medical cannabis (Rho Phyto) product lines and the pharmaceutical
pipeline that is currently under clinical investigation. Dr. Allen will now leverage a recent MITACS
award in addition to this NSERC Alliance grant in collaboration with Avicanna
to develop a cannabinoid-based formulation for treatment of COVID-19 related
lung inflammation.
A second NSERC Alliance grant was
awarded to Dr. Jibran Khokhar, Assistant Professor at the University of Guelph,
who has an extensive track-record in behavioural pharmacology and neuroscience.
Avicanna's research program with Dr. Khokhar focuses on evaluating a variety of
cannabinoids in several preclinical models of human psychiatric conditions including
mental health disorders such as anxiety, depression, and PTSD. The NSERC grant
was awarded to evaluate the neurobiological underpinnings of cannabis toxicosis
in a preclinical model, and test the potential efficacy of Avicanna's
naturally-derived cannabinoids and formulations in the treatment of
cannabis-induced toxicosis. With the recent changes in the Canadian regulations
for Cannabis 2.0 allowing for cannabinoid edibles and vapes, there is concern
around an increased risk for adverse events arising from accidental high-dose
cannabis ingestion. Thus, this two-year project will determine the behavioural
and neural correlations of cannabis-induced toxicosis and the effects of
cannabinoids for counteracting cannabis-induced toxicosis.
Dr Jibran Khokhar, commented,
"This research is extremely timely with the new Cannabis 2.0 regulations
and the increased risk for cannabis-induced toxicosis. I am thankful to NSERC
and Avicanna for support of this important research that will have an impact in
our understanding of the neurobiological underpinnings of, and provide novel
treatment avenues to treat, adverse events related to high-dose cannabis
exposures."
HEXO
Corp
(TSX: HEXO) (NYSE: HEXO) announced the launch of its line of vape
products to both adult-use and medical consumers, across Canada.
“At HEXO, we pride ourselves in
ensuring our consumers have access to high-quality, reliable and consistent
cannabis products,” said Sebastien St. Louis, CEO and co-founder of HEXO Corp.
“We are thrilled to launch our vape products across Canada as we continue to
focus on innovation and launching additional 2.0 products across all of our
brands.”
Prior to releasing its line of
vapes, the Company conducted testing to evaluate the taste, tolerability of
effects and short-term undesired effects of its proprietary terpene blends.
HEXO’s vape products currently
include three ready-to-use vape pens and four 510-thread cartridges, in popular
strain-inspired terpene blends. HEXO vapes are available across Canada to both
adult-use and medical consumers.
Zenabis
Global Inc. (TSX: ZENA) today announced initial shipments of its Re-Up
510-Threaded Vaporizer line.
This week, Zenabis completed first
shipments of this new product line, which is produced at Zenabis Atholville
using product cultivated and extracted by Zenabis, with no requirement for
third-party processing. Currently, the product offering includes two high THC
products and one CBD product. Zenabis currently has listings of this product in
five provinces and anticipates listings in an additional three provinces by the
end of August.
Zenabis anticipates that its
510-Threaded Vaporizer line will contribute meaningfully to net revenue from
August 2020 onward given consumer preference for the Re-Up 510-Threaded
Vaporizer line of products. Thus far, all offers made under the Re-Up 510
Threaded Vaporizer line have been accepted by provincial counterparties. Zenabis has focused on achieving
differentiation in this product line through:
● A focus
on competitive, best-in-class pricing (targeting lowest retail pricing versus
competitors in all available provincial markets); and
● Products
based on terpene flavour profile, as opposed to cultivar.
Zenabis created this product line
with a focus on consumer education and experience. The Re-Up 510-Threaded
Vaporizer line of products was developed by our product development team to
assist consumers in better understanding the botanical nature of terpenes. Each
vaporizer cartridge type was developed with a purposefully curated selection of
terpenes with complementary flavour profiles and similar characteristics. The
initial launch of the
Re-Up 510-Threaded Vaporizer product
line will include two high THC vaporizer cartridges: (i) Lemon and Lavender;
and (ii) Hops and Spice, as well as one high CBD vaporizer cartridge, Pine and
Berry. The Re-Up 510-Threaded Vaporizers product line will be available in two
formats, 0.5g and 1.0g, and fit all standard 510 thread vaporizer pens.
Kevin Coft, Chief Executive Officer
of Zenabis, stated, "We are very excited to have completed initial
shipments under this product line, especially given that this was achieved
through full, internalized production of these products at Zenabis Atholville
utilizing in-house extraction and filling. We believe that the Re-Up 510-Threaded
Vaporizer line is a strong complement to our existing, premium Pax Era line of
vaporizer cartridges." Olen Vanderleeden, Senior Vice President of Zenabis
added, "Based on indications from provincial counterparties and
considering our competitive pricing, Zenabis anticipates incremental monthly
revenue in excess of one million dollars per month once production at Zenabis
Atholville rises to a level to meet consumer demand."
Ehave,
Inc.
(OTC : EHVVF) and its subsidiary PsyTech announced today an upcoming Psychedelic
Industry webinar for investors and interested individuals. PsyTech was
incubated by iCAN (Israel-cannabis) and developed by the team behind CannaTech,
the premier international cannabis summit. Leveraging the highly relevant
experience of iCAN, PsyTech is positioned to lead the global psychedelic
conversation forward.
Ehave CEO Ben Kaplan said, "Our
PsyTech Conferences have been very popular with investors, as a result of their
insight on the industry. Psychedelic medicine has garnered a tremendous amount
of attentions since The U.S. Food and Drug Administration (FDA) authorized
Breakthrough Therapy Designation to both Compass Pathways' and Usona Institute's
psilocybin therapy for depression in 2018." Mr. Kaplan continued,
"The mainstream media started talking about it late last year after a
group of private donors donated $17 million to start the Center for Psychedelic
and Consciousness Research at Johns Hopkins Medicine. We expect our
complimentary webinar on July 29 will continue our trend of providing important
information on psychedelic medicine to investors.''
The virtual investor webinar titled
Mystical Experience, Religion, and Psychedelics is open to individual
investors, institutional investors, advisors, analysts and the Psychedelic
Community. The program opens at 12:00 PM ET on Wednesday, July 29th.
Speakers for the PsyTech Virtual
Investor Conference include:
Irie Selkirk - Moderator
Director of Rise Wellness Retreat
and Co-Founder of Sansero Life Sciences
Pastor James Lindberg
An Ordained Clergy Person at The
Evangelical Lutheran Church in America
Rabbi Zac Kamenetz
Founder and CEO of Shefa:
Psychedelic Therapy Grounded in Jewish Spirituality
William A. Richards
Psychologist - The Center for
Psychedelic And Consciousness Research At The Johns Hopkins University School
Of Medicine
There are no fees to log-in, or
attend the live presentations.
REGISTER NOW AT
https://www.psytech.biz/psytech-mystical-experience-july-29th/
Please support our partner
organization, Mind Medicine Australia, by registering for their upcoming summit
on psychedelic therapies for mental illness. MMA is offering a special 10%
discount code to the PsyTech community. Just use the code ‘MMA2020’ on their website when purchasing an
event package.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
No comments:
Post a Comment